April 15, 2010
Biothera raises $3.5M, looking for more
Biothera has raised $3.5 million and the company doesn’t want to stop there, as it aims to push that total to $25 million, according to a regulatory filing… Biothera is in the midst of Phase 2 trials of its drug, Immprime PGG, with patients suffering from lung cancer, said David Walsh, vice president of […]